Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: Role of the Eph receptors

被引:77
作者
Hess, Angela R. [1 ,2 ]
Margaryan, Naira V. [1 ]
Seftor, Elisabeth A. [1 ]
Hendrix, Mary J. C. [1 ]
机构
[1] Northwestern Univ, Childrens Mem Res Ctr, Feinberg Sch Med, Program Canc Biol & Epigenom, Chicago, IL 60614 USA
[2] Bloomsburg Univ Penn, Dept Biol & Allied Hlth Sci, Bloomsburg, PA 17815 USA
关键词
EphA2; vasculogenic mimicry; melanoma; VE-cadherin; metastasis;
D O I
10.1002/dvdy.21190
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
During embryogenesis, the primordial microcirculation is formed through a process known as vasculogenesis. The term "vasculogenic mimicry" has been used to describe the manner in which highly aggressive, but not poorly aggressive melanoma tumor cells express endothelial and epithelial markers and form vasculogenic-like networks similar to embryonic vasculogenesis. Vasculogenic mimicry is one example of the remarkable plasticity demonstrated by aggressive melanoma cells and suggests that these cells have acquired an embryonic-like phenotype. Since the initial discovery of tumor cell vasculogenic mimicry by our laboratory, we have been focusing on understanding the molecular mechanisms that regulate this process. This review will highlight recent findings identifying key signal transduction events that regulate melanoma vasculogenic mimicry and their similarity to the signal transduction events responsible for promoting embryonic vasculogenesis and angiogenesis. Specifically, this review will focus on the role of the Eph receptors and ligands in embryonic vasculogenesis, angiogenesis, and vasculogenic mimicry. Developmental Dynamics 236:3283-3296, 2007. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:3283 / 3296
页数:14
相关论文
共 108 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]  
[Anonymous], 1997, Cell, V90, P403
[3]   Generation of new human embryonic stem cell lines with diploid and triploid karyotypes [J].
Baharvand, H ;
Ashtiani, SK ;
Taee, A ;
Massumi, M ;
Valojerdi, MR ;
Yazdi, PE ;
Moradi, SZ ;
Farrokhi, A .
DEVELOPMENT GROWTH & DIFFERENTIATION, 2006, 48 (02) :117-128
[4]   An evidence-based staging system for cutaneous melanoma [J].
Balch, CM ;
Soong, SJ ;
Atkins, MB ;
Buzaid, AC ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (03) :131-149
[5]   Molecular classification of cutaneous malignant melanoma by gene expression profiling [J].
Bittner, M ;
Meitzer, P ;
Chen, Y ;
Jiang, Y ;
Seftor, E ;
Hendrix, M ;
Radmacher, M ;
Simon, R ;
Yakhini, Z ;
Ben-Dor, A ;
Sampas, N ;
Dougherty, E ;
Wang, E ;
Marincola, F ;
Gooden, C ;
Lueders, J ;
Glatfelter, A ;
Pollock, P ;
Carpten, J ;
Gillanders, E ;
Leja, D ;
Dietrich, K ;
Beaudry, C ;
Berens, M ;
Alberts, D ;
Sondak, V ;
Hayward, N ;
Trent, J .
NATURE, 2000, 406 (6795) :536-540
[6]   Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis [J].
Brader, S ;
Eccles, SA .
TUMORI JOURNAL, 2004, 90 (01) :2-8
[7]   Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo [J].
Brantley, DM ;
Cheng, N ;
Thompson, EJ ;
Lin, Q ;
Brekken, RA ;
Thorpe, PE ;
Muraoka, RS ;
Cerretti, DP ;
Pozzi, A ;
Jackson, D ;
Lin, C ;
Chen, J .
ONCOGENE, 2002, 21 (46) :7011-7026
[8]   Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice [J].
Brantley-Sieders, Dana M. ;
Fang, Wei Bin ;
Hwang, Yoonha ;
Hicks, Donna ;
Chen, Jin .
CANCER RESEARCH, 2006, 66 (21) :10315-10324
[9]   Eph receptor tyrosine kinases in angiogenesis: From development to disease [J].
Brantley-Sieders D.M. ;
Chen J. .
Angiogenesis, 2004, 7 (1) :17-28
[10]   Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression [J].
Brantley-Sieders, DM ;
Fang, WB ;
Hicks, DJ ;
Zhuang, GL ;
Yu, S ;
Chen, J .
FASEB JOURNAL, 2005, 19 (11) :1884-+